Home / Products / Cancer (Tumor) Cell Lines / HT-29
HT-29
Datasheet Protocol

HT-29

Cat. No. ARC0327
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Large intestine (colon)

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

HT-29 is a cancer cell line of large intestine (colon) adenocarcinoma from Homo sapiens (Human).
 
Synonym: HT 29; HT29

Recommended Products

MSN Knockout NCI-H1975 Polyclonal Cells MSN Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG16741 CES3 Knockout NCI-H1975 Polyclonal Cells CES3 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG16510 P2RX4 Knockout 143B Polyclonal Cells P2RX4 Knockout 143B Polyclonal Cells Cat. No. ARG11858 APOM Knockout Hela Polyclonal Cells APOM Knockout Hela Polyclonal Cells Cat. No. ARG20867 KLF12 Knockout NCI-H1299 Polyclonal Cells KLF12 Knockout NCI-H1299 Polyclonal Cells Cat. No. ARG30933 CCDC91 Knockout jurkat Polyclonal Cells CCDC91 Knockout jurkat Polyclonal Cells Cat. No. ARG43130
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Large intestine (colon)
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
44 years
Sex of Donor:
Female
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CEP63 Knockout NCI-H1299 Polyclonal Cells

CEP63 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17525
 M6PR Knockout HT29 Polyclonal Cells

M6PR Knockout HT29 Polyclonal Cells

Cat. No. ARG15078
 OSGEPL1 Knockout jurkat Polyclonal Cells

OSGEPL1 Knockout jurkat Polyclonal Cells

Cat. No. ARG13384
 PAK1 Knockout HEK293 Polyclonal Cells

PAK1 Knockout HEK293 Polyclonal Cells

Cat. No. ARG12688
 Melk Knockout RAW 264.7 Polyclonal Cells

Melk Knockout RAW 264.7 Polyclonal Cells

Cat. No. ARG12443
 ETFA Knockout 786-O Polyclonal Cells

ETFA Knockout 786-O Polyclonal Cells

Cat. No. ARG5176